Wahl Michael, Anwar Mekhail, Hess Christopher P, Chang Susan M, Lupo Janine M
Department of Radiation Oncology, University of California, San Francisco, CA, USA.
Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA.
Radiat Oncol. 2017 Aug 10;12(1):126. doi: 10.1186/s13014-017-0861-5.
Cranial irradiation is associated with long-term cognitive changes. Cerebral microbleeds (CMBs) have been identified on susceptibility-weighted MRI (SWI) in patients who have received prior cranial radiation, and serve as radiographic markers for microvascular injury thought to contribute to late cognitive decline. The relationship between CMB formation and radiation dose has not previously been quantified.
SWI was performed on 13 patients with stable WHO grade III-IV gliomas between 2 and 4 years after chemoradiotherapy to 60 Gy. The median age at the time of treatment was 41 years (range 25 - 74 years). CMBs were identified as discrete foci of susceptibility on SWI that did not correspond to vessels. CMB density for low (<30 Gy), median (30-45 Gy), and high (>45 Gy) dose regions was computed.
Twelve of 13 patients exhibited CMBs. The number of CMBs was significantly higher for late (>3 years from treatment) compared to early (<3 years) timepoints (early median 6 CMBs; late median 27 CMBs; p = 0.001), and there were proportionally more CMBs at lower doses for late scans (p = 0.006). 88% of all CMBs were observed in regions receiving at least 30 Gy, but the CMB density within medium and high dose regions was not significantly different (p = 0.33 and p = 0.9, respectively, for early and late time points).
CMBs predominantly form in regions receiving at least 30 Gy, but form in lower dose regions with longer follow-up. We do not observe a clear dose-response relationship at doses above 30 Gy. These findings provide important information to assess the risk of late microvascular sequelae from cranial irradiation.
颅脑照射与长期认知改变有关。在接受过颅脑放疗的患者的磁敏感加权成像(SWI)上已发现脑微出血(CMB),其作为微血管损伤的影像学标志物,被认为与晚期认知功能下降有关。此前尚未对CMB形成与辐射剂量之间的关系进行量化。
对13例WHO III-IV级稳定型胶质瘤患者在放化疗至60 Gy后2至4年进行SWI检查。治疗时的中位年龄为41岁(范围25 - 74岁)。CMB被识别为SWI上不与血管对应的离散磁敏感灶。计算低(<30 Gy)、中位(30 - 45 Gy)和高(>45 Gy)剂量区域的CMB密度。
13例患者中有12例出现CMB。与早期(<3年)时间点相比,晚期(治疗后>3年)的CMB数量显著更多(早期中位6个CMB;晚期中位27个CMB;p = 0.001),且晚期扫描时较低剂量区域的CMB比例更高(p = 0.006)。所有CMB的88%出现在接受至少30 Gy的区域,但中高剂量区域内的CMB密度无显著差异(早期和晚期时间点分别为p = 0.33和p = 0.9)。
CMB主要在接受至少30 Gy的区域形成,但在随访时间较长的较低剂量区域也会形成。在30 Gy以上的剂量下,我们未观察到明确的剂量反应关系。这些发现为评估颅脑照射导致晚期微血管后遗症的风险提供了重要信息。